Medicine for treating chronic hepatitis b

A technology for chronic hepatitis B and drugs, applied in the field of drugs for the treatment of chronic hepatitis B, can solve the problems of unsatisfactory curative effect, complicated liver disease mechanism, and neglect of others, and achieves the effects of safe and reliable clinical use, convenient oral administration, and short course of treatment.

Active Publication Date: 2009-02-04
LANZHOU FOCI PHARM CO LTD
View PDF0 Cites 17 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are many types of drugs for the treatment of liver diseases on the market, with different effects. However, compared with the complex mechanism of liver diseases, most drugs seem to care about one thing and lose another, and the curative effect is not ideal.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating chronic hepatitis b
  • Medicine for treating chronic hepatitis b
  • Medicine for treating chronic hepatitis b

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0238] Weigh according to the following ratio:

[0239] Yin Chen 235g Bupleurum 277g Angelica 39g White Peony 115g

[0240] Danshen 475g, Curcuma 39g, Corydalis 277g, Triangle 39g

[0241] Curcuma 39g Rhizoma Cyperi 277g Toosendan 39g Codonopsis 396g

[0242] Atractylodes macrocephala 39g Astragalus membranaceus 712g Poria cocos 475g Citrus aurantium 39g

[0243] Amomum 39g Betel nut 113g Agarwood 19g Licorice 277g

[0244] Medicine of the present invention can obtain big honeyed pill by following method:

[0245] 1. Get Radix Bupleurum, Corydalis Corydalis, Curcuma Rhizoma Rhizoma Rhizoma Rhizoma Rhizoma Rhizoma Corydalis, Cyperus Cyperi according to the vinegar processing method in the processing method under this kind item of Chinese Pharmacopoeia (2005 edition one);

[0246] Get three edges and process according to the processing method stipulated under this item of Chinese Pharmacopoeia (2005 edition one);

[0247] Get Radix Paeoniae Alba, Toosendan to process accord...

Embodiment 2

[0253] Weigh according to the following ratio:

[0254] Yin Chen 450g Bupleurum 135g Angelica 135g White Peony 300g

[0255] Danshen 300g Curcuma 225g Yanhusuo 135g Triangle 135g

[0256] Curcuma 135g Rhizoma Cyperi 135g Toosendan 135g Codonopsis 225g

[0257] Atractylodes macrocephala 135g Astragalus 450g Poria cocos 300g Citrus aurantium 135g

[0258] Amomum 135g Betel nut 135g Agarwood 90g Licorice 135g

[0259] Production method: with embodiment 1 production method.

Embodiment 3

[0261] Weigh according to the following ratio:

[0262] Yin Chen 290g Bupleurum 39g Angelica 277g White Peony 200g

[0263] Danshen 115g, Curcuma 396g, Corydalis 39g, Triangular 277g

[0264] Curcuma 277g Rhizoma Cyperi 39g Toosendan 277g Codonopsis 39g

[0265] Atractylodes macrocephala 277g Astragalus 235g Poria cocos 115g Citrus aurantium 277g

[0266] Amomum 277g Betel nut 277g Agarwood 198g Licorice 39g

[0267] Production method: with embodiment 1 production method.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine for treating chronic hepatitis B, which contains the raw materials by the mixture ratio: 6-18% of herba artemisiae capillaries, 1-7% of Chinese thorowax, 1-7% of angelica, 3-12% of radix paeoniae alba, 3-12% of salvia miltiorrhiza, 1-10% of radix curcumae, 1-7% of rhizoma corydalis, 1-7% of common burreed rhizome, 1-7% of rhizoma zedoariae, 1-7% of nutgrass galingale rhizome, 1-7% of fructus meliae toosendan, 1-10% of dangshen, 1-7% of largehead atractylodes rhizome, 6-18% of radix astragali, 3-12% of indian bread, 1-7% of immature bitter orange, 1-7% of amomum villosum, 1-7% of areca, 0.5-5% of Chinese eaglewood and 1-7% of liquorice; the medicine is prepared by adopting conventional method. The medicine has the efficacies of clearing heat and promoting diuresis, nourishing the liver and invigorating the spleen, regulating the flow of qi and removing blood stasis, and can be used for treating chronic hepatitis B with remarkable effects, short period of treatment and rapid effects.

Description

technical field [0001] The invention belongs to a traditional Chinese medicine preparation, in particular to a medicine for treating chronic hepatitis B. Background technique [0002] Chronic Viral Hepatitis B (CH-B) is a common disease that seriously endangers human health. Its prevention and treatment has become a global public health problem and has attracted the attention of countries all over the world. my country is a high incidence area of ​​viral hepatitis, with an average annual incidence rate of 120-140 / 100,000. Among them, hepatitis B (HB) is the most prominent. The infection rate of hepatitis B virus (HBV) in my country is as high as 57.63%, that is, at least 600 million people in the country have been infected with HBV. The positive rate of HBsAg is 9.75%, about 120 million people, accounting for 1 / 3 of the world; about 1 / 4 of them will develop chronic liver disease, and some patients may develop liver cirrhosis and even liver cancer. Currently there are more...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61K9/00A61K9/16A61K9/20A61K9/48A61P1/16A61P31/20
Inventor 尚寿鹏马德平
Owner LANZHOU FOCI PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap